HOSPITAL AUTHORITY DRUG FORMULARY (v17.1 - w.e.f. 10 Jul 2021) drugs newly added to each category are highlighted in "yellow"
(1) The drugs may either be listed as generic or proprietary names, where appropriate. Brand names listed serve as reference only, they do not necessarily indicate the availability of that particular brand. (2) Some drugs may appear in more than one category due to different formulations and/or indications. (3) The "Special" drugs will be prescribed as clinically indicated based on the specified indications. (4) Based on operational logistics and needs, individual cluster/hospital may only stock part of the drugs listed in the HA Drug Formulary.
Self-financed item Self-financed item BNF General Drugs Special Drugs With Safety Net Without Safety Net 2 CARDIOVASCULAR SYSTEM 心臟科藥物 2.1 POSITIVE INOTROPIC DRUGS DIGOXIN MILRINONE 2.2 DIURETICS AMILORIDE EPLERENONE BUMETANIDE DYAZIDE (OR EQUIV) FRUSEMIDE HYDROCHLOROTHIAZIDE INDAPAMIDE MANNITOL MANNITOL + SORBITOL METOLAZONE MODURETIC (OR EQUIV) SPIRONOLACTONE 2.3 ANTI-ARRHYTHMIC DRUGS AMIODARONE DRONEDARONE ATROPINE DISOPYRAMIDE FLECAINIDE MEXILETINE PROCAINAMIDE PROPAFENONE QUINIDINE 2.4 BETA-ADRENOCEPTOR BLOCKING DRUGS ATENOLOL BISOPROLOL BISOPROLOL + HYDROCHLOROTHIAZIDE CARVEDILOL ESMOLOL LABETALOL METOPROLOL NADOLOL PROPRANOLOL SOTALOL 2.5 HYPERTENSION AND HEART FAILURE CAPTOPRIL AMBRISENTAN CLONIDINE AMLODIPINE + VALSARTAN ENALAPRIL BOSENTAN ENALAPRILAT CANDESARTAN HYDRALAZINE DOXAZOSIN LISINOPRIL ILOPROST LOSARTAN IRBESARTAN IRBESARTAN + METHYLDOPA HYDROCHLOROTHIAZIDE LOSARTAN + MINOXIDIL HYDROCHLOROTHIAZIDE Self-financed item Self-financed item BNF General Drugs Special Drugs With Safety Net Without Safety Net NITROPRUSSIDE DIHYDRATE SODIUM MACITENTAN PERINDOPRIL SACUBITRIL + VALSARTAN PHENOXYBENZAMINE SELEXIPAG PHENTOLAMINE SILDENAFIL (REVATIO) PRAZOSIN TELMISARTAN TELMISARTAN + PREDONIUM (OR EQUIV) HYDROCHLOROTHIAZIDE RAMIPRIL VALSARTAN VALSARTAN + TERAZOSIN HYDROCHLOROTHIAZIDE NITRATES, CALCIUM-CHANNEL BLOCKERS, AND OTHER 2.6 ANTIANGINAL DRUGS AMLODIPINE CILOSTAZOL DILTIAZEM GINKGO BILOBA EXTRACT FELODIPINE ER IVABRADINE GLYCERYL TRINITRATE LERCANIDIPINE GLYCERYL TRINITRATE (PATCH) NAFTIDROFURYL OXALATE ISOSORBIDE DINITRATE NIFEDIPINE ISOSORBIDE MONONITRATE OXPENTIFYLLINE NICERGOLINE NIFEDIPINE NIMODIPINE VERAPAMIL 2.7 SYMPATHOMIMETICS ADRENALINE DOBUTAMINE DOPAMINE EPHEDRINE ISOPRENALINE METARAMINOL MIDODRINE NORADRENALINE NOREPINEPHRINE PHENYLEPHRINE 2.8 ANTICOAGULANTS AND PROTAMINE ARGATROBAN APIXABAN RIVAROXABAN ENOXAPARIN DABIGATRAN EPOPROSTENOL EDOXABAN HEPARIN RIVAROXABAN NADROPARIN PROTAMINE SULPHATE SODIUM CITRATE TINZAPARIN WARFARIN 2.9 ANTIPLATELET DRUGS ASPIRIN ABCIXIMAB TICAGRELOR ASPIRIN + GLYCINE CLOPIDOGREL DIPYRIDAMOLE EPTIFIBATIDE PRASUGREL TICAGRELOR STABLE ANGINA, ACUTE CORONARY SYNDROMES, AND 2.10 FIBRINOLYSIS STREPTOKINASE ALTEPLASE TENECTEPLASE UROKINASE 2.11 ANTIFIBRINOLYTIC DRUGS AND HAEMOSTATICS TRANEXAMIC ACID EMICIZUMAB FACTOR IX FACTOR VIIA FACTOR VIII FACTOR VIII INHIBITOR BYPASSING FRACTION Self-financed item Self-financed item BNF General Drugs Special Drugs With Safety Net Without Safety Net PROTHROMBIN COMPLEX CONCENTRATE 2.12 LIPID-REGULATING DRUGS ALIROCUMAB ATORVASTATIN CHOLESTYRAMINE EVOLOCUMAB EZETIMIBE FENOFIBRATE GEMFIBROZIL ROSUVASTATIN SIMVASTATIN 2.13 LOCAL SCLEROSANTS ETHANOLAMINE OLEATE SODIUM TETRADECYL SULPHATE 2.A MISCELLANEOUS (CARDIOVASCULAR SYSTEM) ADENOSINE TRIPHOSPHATE DISODIUM LEVOSIMENDAN CARDIOPLEGIA (OR EQUIV) TRIMETAZIDINE DAFLON 500 (OR EQUIV) TISSEEL KIT (OR EQUIV) UBIDECARENONE